{"id":1566,"date":"1999-02-01T12:00:00","date_gmt":"1999-02-01T11:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/zur-diagnostik-und-therapie-der-refluxoesophagitis-konsensus-eines-expertengremiums"},"modified":"2022-03-17T14:09:03","modified_gmt":"2022-03-17T13:09:03","slug":"zur-diagnostik-und-therapie-der-refluxoesophagitis-konsensus-eines-expertengremiums","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/zur-diagnostik-und-therapie-der-refluxoesophagitis-konsensus-eines-expertengremiums","title":{"rendered":"Zur Diagnostik und Therapie der Reflux\u00f6sophagitis. Konsensus eines Expertengremiums"},"content":{"rendered":"<p>Ein internationales Expertengremium, an dem auch R. Arnold aus Marburg teilnahm, tagte Ende 1997 an der Yale-Universit\u00e4t New Haven, USA. Im J. Clin. Gastroenterol. (1998, 27, 6) wurde von S.F. Moss et al. \u00fcber die Ergebnisse berichtet, die als der augenblickliche Stand des Wissens zu Diagnostik und Therapie der Reflux\u00f6sophagitis angesehen wurden. Die Reflux\u00f6sophagitis wird [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ein internationales Expertengremium, an dem auch R. Arnold aus Marburg teilnahm, tagte Ende 1997 an der Yale-Universit\u00e4t New Haven, USA. Im J. Clin. Gastroenterol. (1998, 27, 6) wurde von S.F. Moss et al. \u00fcber die Ergebnisse berichtet, die als der augenblickliche Stand des Wissens zu Diagnostik und Therapie der Reflux\u00f6sophagitis angesehen wurden. Die Reflux\u00f6sophagitis wird [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3682,3681,2255,648,649,292,111,291,115,114,3680],"class_list":["post-1566","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antazida","tag-barrett-oesophagus","tag-gastrooesophagealer-reflux","tag-h2-rezeptor-antagonisten","tag-h2-rezeptoren-blocker","tag-lansoprazol","tag-omeprazol","tag-pantoprazol","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-refluxoesophagitis"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1566"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1566\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}